Why does carbamazepine cause so many drug interactions?

Carbamazepine induces hepatic cytochrome P450 enzymes, including inducing its own metabolism (autoinduction), which can lower the concentrations of co-administered drugs and change its own clearance over time. This is a pharmacological property, described here for reference rather than as prescribing advice.

Is oxcarbazepine just a safer version of carbamazepine?

Oxcarbazepine is a structural analogue with a different metabolism and generally fewer enzyme-induction interactions, but it is not simply interchangeable: its evidence base in mood disorders is weaker than carbamazepine's.

Carbamazepine and Oxcarbazepine in Mood Disorders

Carbamazepine is a dibenzazepine anticonvulsant, structurally related to the tricyclic antidepressants, that is used as a mood stabilizer chiefly for acute mania. Oxcarbazepine is a structural analogue (the 10-keto derivative) developed to retain similar activity with a different metabolic profile. Both act primarily by stabilizing voltage-gated sodium channels, and carbamazepine is notable for inducing hepatic drug-metabolizing enzymes.

Finn tema med PaperMindSnartFind papers & topics

Tools & resources

Last ned lysbilder

Learn & explore

VideoSnart

Definition

Carbamazepine is a dibenzazepine anticonvulsant used as a mood stabilizer, principally for acute mania, that acts mainly by use-dependent blockade of voltage-gated sodium channels; oxcarbazepine is its 10-keto analogue with a related mechanism and a different metabolic and interaction profile.

Scope

This entry covers the pharmacology of carbamazepine and its analogue oxcarbazepine as used in mood disorders, their shared sodium-channel mechanism, carbamazepine's autoinduction of metabolism and consequent drug interactions, and the trial and guideline evidence for the antimanic role. It is a pharmacological reference, not prescribing guidance.

Core questions

How do carbamazepine and oxcarbazepine stabilize neuronal membranes?
Why is carbamazepine prone to causing drug interactions?
How does oxcarbazepine differ pharmacologically from carbamazepine?
What is the evidence for carbamazepine in acute mania?

Key concepts

Dibenzazepine structure
Use-dependent sodium-channel blockade
Hepatic enzyme autoinduction
Cytochrome P450 drug interactions
Oxcarbazepine as a metabolic analogue
Hematologic and dermatologic safety considerations

Key theories

Use-dependent sodium-channel blockade: Carbamazepine and oxcarbazepine bind preferentially to inactivated voltage-gated sodium channels, limiting high-frequency repetitive firing; this membrane-stabilizing action is the principal proposed mechanism underlying both anticonvulsant and antimanic effects.

Mechanisms

Carbamazepine and oxcarbazepine act mainly by use- and voltage-dependent blockade of voltage-gated sodium channels, stabilizing neuronal membranes and reducing high-frequency repetitive firing; this is the shared basis proposed for their anticonvulsant and antimanic effects (Weisler 2005). Carbamazepine is metabolized by the hepatic cytochrome P450 system and induces those enzymes, including induction of its own metabolism (autoinduction), which produces clinically important drug interactions and changing clearance over time. Oxcarbazepine, the 10-keto analogue, is metabolized largely by reduction to an active monohydroxy derivative and has a different and generally less inducing interaction profile, although the comparative mood-disorder evidence base is more limited.

Clinical relevance

Guidelines and reviews position carbamazepine among options for acute mania, with extended-release monotherapy supported by randomized placebo-controlled evidence, while noting its interaction burden and safety monitoring requirements (Weisler 2005; Yatham 2018; Geddes 2013). Oxcarbazepine is sometimes used as a better-tolerated analogue but with weaker evidence in mood disorders. This entry describes the pharmacology and evidence and is not a basis for individual treatment decisions.

Evidence & guidelines

A multicenter randomized, double-blind, placebo-controlled trial supported extended-release carbamazepine monotherapy in acute mania (Weisler 2005), and treatment guidelines incorporate carbamazepine among antimanic options while reflecting the comparatively limited mood-disorder evidence for oxcarbazepine (Yatham 2018; Geddes 2013).

History

Carbamazepine was introduced as an anticonvulsant and for trigeminal neuralgia before reports, notably from work associated with Robert Post and colleagues, drew attention to its antimanic potential. Randomized evidence such as the extended-release monotherapy trials later strengthened its psychiatric evidence base, and oxcarbazepine was developed as a structural analogue with an altered metabolic profile (Weisler 2005).

Debates

Does oxcarbazepine share carbamazepine's antimanic efficacy?: Oxcarbazepine is pharmacologically related and better tolerated in some respects, but the controlled evidence for efficacy in mood disorders is substantially weaker than for carbamazepine, leaving its role uncertain.

Key figures

Richard Weisler
Robert Post
John Geddes

Seminal works

weisler-2005
yatham-2018

Frequently asked questions

Why does carbamazepine cause so many drug interactions?: Carbamazepine induces hepatic cytochrome P450 enzymes, including inducing its own metabolism (autoinduction), which can lower the concentrations of co-administered drugs and change its own clearance over time. This is a pharmacological property, described here for reference rather than as prescribing advice.
Is oxcarbazepine just a safer version of carbamazepine?: Oxcarbazepine is a structural analogue with a different metabolism and generally fewer enzyme-induction interactions, but it is not simply interchangeable: its evidence base in mood disorders is weaker than carbamazepine's.